Xenetic Biosciences Inc
Biotechnology
Healthcare
XBIO
1.54 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
3.18
52 week high
4.58
high
3.33
52 week low
0.00
low
3.18
growth
-18.64 %
previous Close
3.12
P/E ratio
market cap
4.51 M
div yield
0
usd
Jun 2025
qoq
revenue
590 K
-0.57 %
net incoming
-688.70 K
23.74 %
eps
0.00 %
23.73 %
eps surprise
29.69 %
net profit margin
-116.75 %
35.00 %
operating incoming
-724.41 K
23.13 %
net change in cash
-383.83 K
61.69 %
cash on hand
4.78 M
-7.43 %
cost of revenue
0.00 %
top top